Medical Condition News

RSS

Biomarker test available for breast cancer, but remains unclear for patients with intermediate risk of recurrence

To make a decision for or against adjuvant chemotherapy, a test to measure the concentrations of the biomarkers uPA and PAI-1 in the tumour tissue is available for breast cancer patients.

21 Oct 2014

Dexcom SHARE CGM remote mobile communications device receives FDA approval

Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.

21 Oct 2014

New SPANS assessment can help patients recover from traumatic brain injuries

A dynamic new assessment for helping victims of trauma to the brain, including those suffering from progressive conditions such as dementia, has been developed by a clinical neuropsychologist at the University of Leicester.

21 Oct 2014

Researchers develop low-cost 3-D printed facial prostheses for eye cancer patients

Researchers have developed a fast and inexpensive way to make facial prostheses for eye cancer patients using facial scanning software and 3-D printing, according to findings released today at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology.

21 Oct 2014

ECMO improves survival, neurological outcomes in patients suffering from cardiac arrest

A new study shows that survival and neurological outcomes for patients in cardiac arrest can be improved by adding extracorporeal membrane oxygenation (ECMO) when performing cardiopulmonary resuscitation (CPR).

21 Oct 2014

Lactobacillus-containing probiotics can improve lupus symptoms

Lactobacillus species, commonly seen in yogurt cultures, correlate, in the guts of mouse models, with mitigation of lupus symptoms, while Lachnospiraceae, a type of Clostridia, correlate with worsening, according to research published ahead of print in Applied and Environmental Microbiology.

21 Oct 2014

CPS students and staff received EAIs for acute allergic reactions

During the 2012-2013 school year, 38 Chicago Public School (CPS) students and staff were given emergency medication for potentially life-threatening allergic reactions.

21 Oct 2014

New study reveals how cancer becomes drug resistant over time

Like a colony of bacteria or species of animals, cancer cells within a tumor must evolve to survive. A dose of chemotherapy may kill hundreds of thousands of cancer cells, for example, but a single cell with a unique mutation can survive and quickly generate a new batch of drug-resistant cells, making cancer hard to combat.

21 Oct 2014

Renowned photographer creates 'Profiles of LBD' portrait series to support LBD campaign

In honor of Lewy Body Dementia (LBD) Awareness Month, the Lewy Body Dementia Association proudly unveils, "The Profiles of LBD," a portrait series of families living with the disease.

21 Oct 2014

Infection with herpes simplex virus increases Alzheimer's risk

Infection with herpes simplex virus increases the risk of Alzheimer's disease. Researchers at Umeå University, Sweden, claim this in two studies in the journal Alzheimer's & Dementia.

20 Oct 2014

IOF data shows 93% of US adults are unaware of men’s susceptibility to osteoporosis

New survey findings released by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day show that on average, 93 percent of nearly 1,200 adults surveyed are unaware how common osteoporotic fractures are in men.

20 Oct 2014

Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in 2009 to focus on epigenetic therapy in cancer treatment, will continue with the commitment of $7.5 million from Van Andel Research Institute (VARI).

20 Oct 2014

Asterias, CIRM sign NGA to begin AST-OPC1 study for complete cervical spinal cord injury

Asterias Biotherapeutics, Inc. announced today that the Company has signed a Notice of Grant Award (NGA) with the California Institute of Regenerative Medicine (CIRM), effective October 1, 2014.

20 Oct 2014

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures.

20 Oct 2014

Aspirin can improve efficacy of schizophrenia treatments

A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.

20 Oct 2014

National nursing organizations collaborate to transform care for patients with serious illness

Three national nursing organizations today announced a collaborative effort to transform the care and culture of serious illness in the United States.

20 Oct 2014

Qualified massage therapist can play key role in improving cardiovascular health

Many already view massage as an important approach to relieving muscle pain or as a means to relax. However, working with a qualified massage therapist can also play a significant role in improving cardiovascular health as evidenced by a growing body of research, according to the American Massage Therapy Association.

20 Oct 2014

Autonomic dysfunction highly prevalent in Parkinson's disease, regardless of age, disease duration

New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration.

20 Oct 2014

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System in underserved patient populations, including women and people of color.

20 Oct 2014

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc.

20 Oct 2014

Medical Condition News

Biomarker test available for breast cancer, but remains unclear for patients with intermediate risk of recurrence

Dexcom SHARE CGM remote mobile communications device receives FDA approval

New SPANS assessment can help patients recover from traumatic brain injuries

Researchers develop low-cost 3-D printed facial prostheses for eye cancer patients

ECMO improves survival, neurological outcomes in patients suffering from cardiac arrest

Lactobacillus-containing probiotics can improve lupus symptoms

CPS students and staff received EAIs for acute allergic reactions

New study reveals how cancer becomes drug resistant over time

Renowned photographer creates 'Profiles of LBD' portrait series to support LBD campaign

Infection with herpes simplex virus increases Alzheimer's risk

IOF data shows 93% of US adults are unaware of men’s susceptibility to osteoporosis

Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

Asterias, CIRM sign NGA to begin AST-OPC1 study for complete cervical spinal cord injury

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Aspirin can improve efficacy of schizophrenia treatments

National nursing organizations collaborate to transform care for patients with serious illness

Qualified massage therapist can play key role in improving cardiovascular health

Autonomic dysfunction highly prevalent in Parkinson's disease, regardless of age, disease duration

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News